UK secures drug price cut in exchange for measures on innovation

The UK government has reached an agreement in principle with the pharmaceutical industry to create incentives for primary care physicians to prescribe new medicines  in exchange for a voluntary 2% reduction in the prices charged to the National Health Service (NHS) for branded medicines.

Location